Cervical cancer is the fourth leading cancer worldwide in women, ranking only after breast cancer, colorectal cancer, and lung cancer. Because it is typically diagnosed at a younger age compared to other major cancer types, it leads to a proportionally greater loss in life-years. Most cancers occur in squamo-columnar junction, the transition point between squamous and columnar cells; squamous cell carcinoma accounts for approximately 70% of cervical cancer cases. Treatment options vary depending on the stage at diagnosis and include surgery (conization or hysterectomy), radiation, chemotherapy, targeted therapy, and immunotherapy. Prognosis is affected by stage, tumor volume, age and performance status, and treatment type.

Local recurrence of cervical cancer is not uncommon. It is known to metastasize to distance sites including the lung, liver, bone, and supraclavicular lymph nodes, with rare cases involving the breast, paraspinal muscles and duodenum. Metastatic spread of cancer from extracolonic origin to the colon is uncommon. It occurs very rarely in breast and lung carcinomas (~2%), as well as stomach, prostate, breast, ovarian and melanoma This is a care case of a recurrence of cervical cancer that spread to the colon and presented as a sigmoid lesion.